BACKGROUND: Cystic fibrosis (CF) is a rare multi-systemic recessive disorder. The spectrum and the frequencies of CFTR mutations causing CF vary amongst different populations in Europe and the Middle East. In this study, we characterised the distribution of CF-causing mutations (i.e. pathogenic variants in the CFTR gene) in a representative CF cohort from the Kingdom of Bahrain based on a three-decade-long analysis at a single tertiary centre. We aim to improve CF genetic diagnostics, introduce of CF neonatal screening and provide CFTR modulator therapy (CFTRm). METHODS: CFTR genotyping and associated clinical information were drawn from a longitudinal cohort. We sequenced 56 people with CF (pwCF) that had one or both CFTR mutations unidentified and carried out comprehensive bioinformatic- and family-based segregation analyses of detected variants, including genotype-phenotype correlations and disease incidence estimates. The study methodology could serve as a basis for other non-European CF populations with a high degree of consanguinity. RESULTS: Altogether 18 CF-causing mutations were identified, 15 of which were not previously detected in Bahrain, accounting for close to 100% of all population-specific alleles. The most common alleles comprise c.1911delG [2043delG; 22.8%], c.2988+1G > A [3120+1G>A; 16.3%], c.2989-1G>A [3121-1G>A; 14.1%], c.3909C>G [N1303K; 13.0%], and c.1521_1523delCTT [p.PheF508del; 7.6%]. Although the proportion of 1st cousin marriages has decreased to 50%, the frequency of homozygosity in our pwCF is 67.4%, thereby indicating that CF still occurs in large, often related, families. pwCF in Bahrain present with faltering growth, pancreatic insufficiency and classical sino-pulmonary manifestations. Interestingly, two pwCF also suffer from sickle cell disease. The estimated incidence of CF in Bahrain based on data from the last three decades is 1 in 9,880 live births. CONCLUSION: The most commonCF-causing mutations in Bahraini pwCF were identified, enabling more precise diagnosis, introduction of two-tier neonatal screening and fostering administration of CFTRm.

Department of Biology and Medical Genetics 2nd Faculty of Medicine and Motol University Hospital Charles University Prague Czechia

Department of Pediatrics University Hospital in Coventry and Warwickshire Coventry United Kingdom

Royal University of Surgeons in Ireland Medical University of Bahrain Al Sayh Muharraq Governorate Busaiteen Kingdom of Bahrain

Salmaniya Medical Complex Rd No 2904 Manama Kingdom of Bahrain

Zobrazit více v PubMed

Afzal M, Ali SM, Siyal HB. Consanguineous marriages in Pakistan. Pakistan Development Review. 1994;33(4 Pt 2):663–674. doi: 10.30541/v33i4IIpp.663-676. PubMed DOI

Al Arrayed SS, Abdulla F. Incidence of cystic fibrosis in Bahrain. J Bahr Med Soc. 1996;8:3.

Al Arrayed SS, Haites N. Features of sickle-cell disease in Bahrain. East Mediterr Health J. 1995;1(1):112–119. doi: 10.26719/1995.1.1.112. DOI

Alibakhshi R, Kianishirazi R, Cassiman JJ, Zamani M, Cuppens H. Analysis of the CFTR gene in Iranian Cystic Fibrosis Patients: Identification of eight novel mutations. J Cyst Fibr. 2008;7(2):102–109. doi: 10.1016/j.jcf.2007.06.001. PubMed DOI

Al-Kindy H, Ouhtit A, Al-Salmi Q, Al-Bimani M, Al-Nabhani M, Gupta I. Novel Mutation in the CFTR Gene of Cystic Fibrosis Patients in Oman. J Mol Biomark Diagn. 2014 doi: 10.4172/2155-9929.1000168. DOI

Al-Mahroos F. Cystic Fibrosis in Bahrain Incidence, Phenotype, and Outcome. J Trop Pediatr. 1998;44(1):35–39. doi: 10.1093/tropej/44.1.35. PubMed DOI

Al-Snan NR, Messaoudi SA, Khubrani YM, Wetton JH, Jobling MA, Bakhiet M. Geographical structuring and low diversity of paternal lineages in Bahrain are shown by analysis of 27 Y-STRs. Mol Genet Genomics. 2020;295:1315–1324. doi: 10.1007/s00438-020-01696-4. PubMed DOI PMC

Banjar H. Sickle Cell Disease and Cystic Fibrosis. Saudi Med J. 2003;24(1):97100. PubMed

Banjar H, Angyalosi G. The road for survival improvement of cystic fibrosis patients in Arab countries. Int J Pediatr Adoles Med. 2015;2(2):47–58. doi: 10.1016/j.ijpam.2015.05.006. PubMed DOI PMC

Banjar H, Tuleimat L, El Seoudi AA, Mogarri I, Alhaider S, Nizami IY, Moghrabi N. Genotype patterns for mutations of the cystic fibrosis transmembrane conductance regulator gene: a retrospective descriptive study from Saudi Arabia. Ann Saudi Med. 2020;40(1):15–24. doi: 10.5144/0256-4947.2020.15. PubMed DOI PMC

Bittles AH. Endogamy, consanguinity and community genetics. J Genet. 2002;81(3):91–98. doi: 10.1007/BF02715905. PubMed DOI

Boek KD. Cystic Fibrosis in the Year 2020: A Disease With a New Face. Acta Pediatrica. 2020;109(5):893–899. doi: 10.1111/apa.15155. PubMed DOI

Claustres, M., Guittard, C., Bozon, D., Chevalier, F., Verlingue, C., Ferec, C., Georges, M.D. (2000). Spectrum of CFTR Mutations in Cystic Fibrosis and in Congenital Absence of the Vas Deferens in France. Human Mutation, 16(2), 143–156. (10.1002/1098-1004(200008)16:2<143::AID-HUMU7>3.0.CO;2-J) Cystic Fibrosis Mutation Database. http://www.genet.sickkids.on.ca/ PubMed

Dooki EMR, Tabaripour R, Rahimi R, Akhavan-Niaki H. Mutation and New Polymorphisms Insight in Introns 11 to 14a of CFTR gene of Northern Iranian Cystic Fibrosis Patients. Gene. 2015;564(2):193–196. doi: 10.1016/j.gene.2015.03.056. PubMed DOI

Dunnen D, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, Taschner PE. HGVS Recommendations for the Description of Sequence Variants: 2016 Update. Human Mutat. 2016;37(6):564–569. doi: 10.1002/humu.22981. PubMed DOI

El-Harith EA, Dörk T, Stuhrmann M, Abu-Srair H, Al-Shahri A, Keller KM, Schmidtke J. Novel and characteristic CFTR mutations in Saudi Arab children with severe cystic fibrosis. J Med Gen. 1997;34(12):996–999. doi: 10.1136/jmg.34.12.996. PubMed DOI PMC

Eskandarani HA. Cystic Fibrosis Transmembrane Regulator Gene Mutations in Bahrain. J Trop Pediatr. 2002;48(6):348–350. doi: 10.1093/tropej/48.6.348. PubMed DOI

European Cystic Fibrosis Society. (2020). ECFS Patient Registry Annual Data Report 2020 (pp. 7, 50, 104). Denmark: European Cystic Fibrosis Society. Retrieved from (https://www.ecfs.eu/sites/default/files/ECFSPR_Report_2020_v1.0%20%2807Jun2022%29_website.pdf)

Farhat R, Puissesseau G, El-Seedy A, Pasquet MC, Adolphe C, Corbani S, Ladeveze V. N1303K (c.3909C>G) Mutation and Splicing: Implication of Its c.[744–33GATT(6); 869+11C>T] Complex Allele in CFTR Exon 7 Aberrant Splicing. BioMed Res Int. 2015 doi: 10.1155/2015/138103. PubMed DOI PMC

Farra C, Menassa R, Awwad J, Morel Y, Salameh P, Yazbeck N, Cabet F. Mutational spectrum of cystic fibrosis in the Lebanese population. J Cyst Fibr. 2010;9(6):406–410. doi: 10.1016/j.jcf.2010.08.001. PubMed DOI

Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N, Sosnay PR. Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation. J Pediatr. 2017 doi: 10.1016/j.jpeds.2016.09.064. PubMed DOI

Growth Charts - Clinical Growth Charts. (2017, June 16). Centers for Disease Control and Prevention. (https://www.cdc.gov/growthcharts/clinical_charts.htm)

Islam MM, Ababneh FM, Khan MHR. Consanguineous marriage in Jordan: An Update. J Biosoc Sci. 2018;50(4):573–578. doi: 10.1017/S0021932017000372. PubMed DOI

Jurdi R, Saxena P. the prevalence and correlates of consanguineous marriages in Yemen: similarities and contrasts with other Arab countries. J Biosoc Sci. 2003;35(1):1–13. doi: 10.1017/S002193200300001). PubMed DOI

Kambouris M, Banjar H, Moggari I, Nazer H, Al-Hamed M, Meyer BF. Identification of Novel Mutations in Arabs With Cystic Fibrosis and Their Impact on the Cystic Fibrosis Transmembrane Regulator Mutation Detection Rate in Arab Populations. Europ J Pediatr. 2000;159(5):303–309. doi: 10.1007/s004310051277. PubMed DOI

Macek M, Mackova A, Hamosh A, Hilman BC, Selden RF, Lucotte G, Cutting GR. Identification of common cystic fibrosis mutations in African Americans with cystic fibrosis increases the detection rate to 75% Am J Hum Gen. 1997;60(5):1122–1127. PubMed PMC

Morral N, Bertranpetit J, Estivill X, Nunes V, Casals T, Gimenez J, Kadasi L. The origin of the major cystic fibrosis mutation (delta F508) in European populations. Nat Genet. 1994;7(2):169–175. doi: 10.1038/ng0694-169. PubMed DOI

Oskooei VK, Dooki EMR, Tabaripour R, Mirzajani S, Pourbagher R, Akhavan-Niaki H. CFTR haplotypes in northern Iranian population. Gene. 2013;512(1):55–60. doi: 10.1016/j.gene.2012.09.096. PubMed DOI

Othman H, Saadat M. Prevalence of consanguineous marriages in Syria. J Biosoc Sci. 2009;41(5):685–692. doi: 10.1017/S0021932009003411. PubMed DOI

Padoa C, Goldman A, Jenkins T, Ramsay M. Cystic fibrosis carrier frequencies in populations of African origin. J Med Genet. 1999;36:41–44. PubMed PMC

Quint A, Lerer I, Sagi M, Abeliovich D. Mutation spectrum in Jewish Cystic Fibrosis Patients in Israel: Implication to Carrier Screening. Am J Med Genet Part A. 2005;136(3):246–248. doi: 10.1002/ajmg.a.30823. PubMed DOI

Reish O, Borochowitz ZU, Adir V, Shohat M, Karpati M, Shtorch A, Chapman SD. Dynamic Modification Strategy of the Israeli Carrier Screening protocol: inclusion of the Oriental Jewish Group to the Cystic Fibrosis Panel. Genet Med. 2009;11(2):101–103. doi: 10.1097/GIM.0b013e31818efd59. PubMed DOI

Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Tsui L. Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA. Science. 1998;245(4922):1066–1073. doi: 10.1126/science.2475911. PubMed DOI

Sirdah MM. Consanguinity profile in the Gaza Strip of Palestine: a large-scale community-based study. Eur J Med Genet. 2014;57(2–3):90–94. doi: 10.1016/j.ejmg.2014.01.003. PubMed DOI